Reviewing Zimmer Biomet Holdings (ZBH) and The Competition
Zimmer Biomet Holdings (NYSE: ZBH) is one of 84 publicly-traded companies in the “Medical Equipment, Supplies & Distribution” industry, but how does it weigh in compared to its competitors? We will compare Zimmer Biomet Holdings to related companies based on the strength of its analyst recommendations, valuation, institutional ownership, dividends, profitability, earnings and risk.
This table compares Zimmer Biomet Holdings and its competitors’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Zimmer Biomet Holdings||9.12%||16.70%||6.18%|
|Zimmer Biomet Holdings Competitors||-128.72%||-37.35%||-10.53%|
This is a summary of current ratings for Zimmer Biomet Holdings and its competitors, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Zimmer Biomet Holdings||1||6||13||1||2.67|
|Zimmer Biomet Holdings Competitors||322||1477||2588||105||2.55|
Zimmer Biomet Holdings presently has a consensus target price of $138.68, suggesting a potential upside of 20.10%. As a group, “Medical Equipment, Supplies & Distribution” companies have a potential upside of 4.63%. Given Zimmer Biomet Holdings’ stronger consensus rating and higher possible upside, equities research analysts clearly believe Zimmer Biomet Holdings is more favorable than its competitors.
Risk & Volatility
Zimmer Biomet Holdings has a beta of 1.21, indicating that its stock price is 21% more volatile than the S&P 500. Comparatively, Zimmer Biomet Holdings’ competitors have a beta of 1.08, indicating that their average stock price is 8% more volatile than the S&P 500.
Zimmer Biomet Holdings pays an annual dividend of $0.96 per share and has a dividend yield of 0.8%. Zimmer Biomet Holdings pays out 27.6% of its earnings in the form of a dividend. As a group, “Medical Equipment, Supplies & Distribution” companies pay a dividend yield of 0.8% and pay out 37.3% of their earnings in the form of a dividend.
Institutional and Insider Ownership
85.5% of Zimmer Biomet Holdings shares are owned by institutional investors. Comparatively, 63.4% of shares of all “Medical Equipment, Supplies & Distribution” companies are owned by institutional investors. 1.1% of Zimmer Biomet Holdings shares are owned by company insiders. Comparatively, 13.0% of shares of all “Medical Equipment, Supplies & Distribution” companies are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Earnings & Valuation
This table compares Zimmer Biomet Holdings and its competitors gross revenue, earnings per share and valuation.
|Gross Revenue||EBITDA||Price/Earnings Ratio|
|Zimmer Biomet Holdings||$7.78 billion||$2.80 billion||33.18|
|Zimmer Biomet Holdings Competitors||$827.05 million||$159.46 million||33.79|
Zimmer Biomet Holdings has higher revenue and earnings than its competitors. Zimmer Biomet Holdings is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.
Zimmer Biomet Holdings beats its competitors on 12 of the 15 factors compared.
Zimmer Biomet Holdings Company Profile
Zimmer Biomet Holdings, Inc. is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products. The Company’s products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. The Company manages its operations through three geographic operating segments: the Americas, consisting principally of the United States and other North, Central and South American markets; EMEA, consisting principally of Europe and the Middle East and African markets, and Asia Pacific, consisting primarily of Japan and other Asian and Pacific markets. The Company’s product category segments include Americas Spine, Office Based Technologies, Craniomaxillofacial and Thoracic (CMF), and Dental.
Receive News & Ratings for Zimmer Biomet Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zimmer Biomet Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.